- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00643383
A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain
April 30, 2012 updated by: Labopharm Inc.
A multi-center placebo controlled, double-blind, trial comparing the analgesic efficacy and safety of Acetram Contramid® BID versus placebo for the treatment of acute low back pain in patients between 18 and 80 yrs of age.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
277
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Quebec, Canada, G1G4A2
-
Quebec, Canada, G1V4X7
-
-
New Brunswick
-
Bathurst, New Brunswick, Canada, E2A4X7
-
-
Newfoundland and Labrador
-
Mount Pearl, Newfoundland and Labrador, Canada, A1N1W7
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y5G8
-
Newmarket, Ontario, Canada, L3Y7V1
-
Sarnia, Ontario, Canada, N7T4X3
-
Sudbury, Ontario, Canada, P3E1H5
-
Toronto, Ontario, Canada, M9W4L6
-
Toronto, Ontario, Canada, M9V4B4
-
-
Quebec
-
Cowansville, Quebec, Canada, J2K2X9
-
Drummondville, Quebec, Canada, J2B7T1
-
Gatineau, Quebec, Canada, J9A1K7
-
Granby, Quebec, Canada, J2G8Z9
-
Mirabel, Quebec, Canada, J7J2K8
-
Montreal, Quebec, Canada, H1S3A9
-
Montreal, Quebec, Canada, H4N2W2
-
Pointe-Claire, Quebec, Canada, H9R4S3
-
Sherbrooke, Quebec, Canada, J1H1Z1
-
Trois-Rivieres, Quebec, Canada, G8T7A1
-
-
-
-
Alabama
-
Montgomery, Alabama, United States, 36117
-
-
Colorado
-
Centennial, Colorado, United States, 80112
-
-
Florida
-
Hialeah, Florida, United States, 33013
-
Largo, Florida, United States, 33770
-
New Port Richey, Florida, United States, 34652
-
-
Indiana
-
Indianapolis, Indiana, United States, 46254
-
-
Iowa
-
Waterloo, Iowa, United States, 50702
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70809
-
-
Massachusetts
-
Brockton, Massachusetts, United States, 02301
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55415
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73112
-
-
South Dakota
-
Rapid City, South Dakota, United States, 57702
-
-
Tennessee
-
Crossville, Tennessee, United States, 38555
-
-
Texas
-
Bryan, Texas, United States, 77082
-
Dallas, Texas, United States, 75235
-
Houston, Texas, United States, 77074
-
-
Utah
-
Salt Lake City, Utah, United States, 84121
-
Salt Lake City, Utah, United States, 84109
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males or females in generally good health aged 18-80 years with moderate to severe acute low back pain.
- Current acute low back pain episode within 48h prior to study entry.
- Pain must be moderate to severe following incident
Exclusion Criteria:
- Chronic low back pain
- Ongoing or history of alcohol or drug abuse
- Body Mass Index greater 39
- Treatment within the last 3 weeks with monoamine oxidase inhibitors; tricyclic antidepressants and other tricyclic compounds; neuroleptics; selective serotonin reuptake inhibitors
- Known history or symptoms suspicious for cancer
- Significant renal or liver disease
- Spinal surgery within 1 year of study entry.
- Subjects who are pregnant or lactating.
- Subjects with unstable medical disease.
- Subjects who have received treatment with an investigational product/device with 30 days prior to study entry.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 2
|
|
|
Active Comparator: 1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Pain Intensity change from Baseline
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Safety evaluation
|
|
Overall satisfaction with the study medication
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
January 1, 2009
Study Completion (Actual)
February 1, 2009
Study Registration Dates
First Submitted
March 20, 2008
First Submitted That Met QC Criteria
March 25, 2008
First Posted (Estimate)
March 26, 2008
Study Record Updates
Last Update Posted (Estimate)
May 1, 2012
Last Update Submitted That Met QC Criteria
April 30, 2012
Last Verified
April 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06CCL3-001
- NCT00643383 (Registry Identifier: ClinicalTrials.gov)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Low Back Pain
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Iran University of Medical SciencesRecruiting
-
Bern University of Applied SciencesUniversity of Zurich; University of Southern Denmark; University of Applied Sciences...Not yet recruitingAcute Low Back Pain | Chronic Low Back Pain (CLBP)
-
MMJ Labs LLCNational Institute on Drug Abuse (NIDA); Sport and Spine Rehab Clinical Research...CompletedChronic Low-back Pain | Pain, Intractable | Acute Low-back PainUnited States
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
-
University Hospital MuensterCompletedAcute Low Back Pain (Low Back Pain for Less Than 3 Months)Germany
-
Xiaonan HuangNot yet recruiting
-
Cliniques universitaires Saint-Luc- Université...CompletedChronic Low Back Pain | Acute Low Back Pain
-
NVP HealthcareCompletedAcute Low Back PainKorea, Republic of
-
NVP HealthcareCompletedAcute Low Back PainKorea, Republic of
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of